

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.14393711 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.14393711 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.79232867 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.79232867 |
| 5 | presynaptic membrane assembly (GO:0097105) | 6.41505730 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.23706701 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.17291580 |
| 8 | postsynaptic membrane organization (GO:0001941) | 5.82783124 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 5.73875544 |
| 10 | presynaptic membrane organization (GO:0097090) | 5.54220105 |
| 11 | urea cycle (GO:0000050) | 5.53230903 |
| 12 | urea metabolic process (GO:0019627) | 5.53230903 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.41586687 |
| 14 | tryptophan catabolic process (GO:0006569) | 5.29825438 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 5.29825438 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 5.29825438 |
| 17 | kynurenine metabolic process (GO:0070189) | 5.24978910 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.22364886 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.16417880 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.16166738 |
| 21 | cysteine metabolic process (GO:0006534) | 5.08516986 |
| 22 | nitrogen cycle metabolic process (GO:0071941) | 5.08041149 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.04065437 |
| 24 | complement activation, alternative pathway (GO:0006957) | 5.03660152 |
| 25 | tryptophan metabolic process (GO:0006568) | 5.01555319 |
| 26 | regulation of triglyceride catabolic process (GO:0010896) | 5.00362695 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.90054038 |
| 28 | protein carboxylation (GO:0018214) | 4.90054038 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86534138 |
| 30 | bile acid metabolic process (GO:0008206) | 4.83814881 |
| 31 | regulation of protein activation cascade (GO:2000257) | 4.81170255 |
| 32 | regulation of fibrinolysis (GO:0051917) | 4.80029360 |
| 33 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.77149344 |
| 34 | homocysteine metabolic process (GO:0050667) | 4.70128659 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 4.69672463 |
| 36 | acylglycerol homeostasis (GO:0055090) | 4.66345208 |
| 37 | triglyceride homeostasis (GO:0070328) | 4.66345208 |
| 38 | regulation of cholesterol esterification (GO:0010872) | 4.65413634 |
| 39 | plasma lipoprotein particle clearance (GO:0034381) | 4.62080632 |
| 40 | reverse cholesterol transport (GO:0043691) | 4.61287384 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.55785053 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 4.55785053 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.55785053 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.51903810 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 4.50175152 |
| 46 | neuron cell-cell adhesion (GO:0007158) | 4.50106187 |
| 47 | regulation of complement activation (GO:0030449) | 4.49562124 |
| 48 | lysine catabolic process (GO:0006554) | 4.46085517 |
| 49 | lysine metabolic process (GO:0006553) | 4.46085517 |
| 50 | aromatic amino acid family metabolic process (GO:0009072) | 4.44885341 |
| 51 | phospholipid efflux (GO:0033700) | 4.41687995 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 4.36624649 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 4.27167852 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.27167852 |
| 55 | cellular ketone body metabolic process (GO:0046950) | 4.23697364 |
| 56 | bile acid and bile salt transport (GO:0015721) | 4.18552042 |
| 57 | nonmotile primary cilium assembly (GO:0035058) | 4.17131014 |
| 58 | cholesterol efflux (GO:0033344) | 4.12281992 |
| 59 | positive regulation of lipid catabolic process (GO:0050996) | 4.07239927 |
| 60 | cellular amino acid catabolic process (GO:0009063) | 4.05884151 |
| 61 | cellular glucuronidation (GO:0052695) | 4.03639427 |
| 62 | drug catabolic process (GO:0042737) | 3.99032958 |
| 63 | plasma lipoprotein particle assembly (GO:0034377) | 3.98310388 |
| 64 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.97101131 |
| 65 | limb bud formation (GO:0060174) | 3.94561345 |
| 66 | coenzyme catabolic process (GO:0009109) | 3.93903153 |
| 67 | axonal fasciculation (GO:0007413) | 3.93458560 |
| 68 | ethanol oxidation (GO:0006069) | 3.92760396 |
| 69 | acetyl-CoA metabolic process (GO:0006084) | 3.91816205 |
| 70 | mechanosensory behavior (GO:0007638) | 3.90988465 |
| 71 | phospholipid homeostasis (GO:0055091) | 3.89762620 |
| 72 | glycine metabolic process (GO:0006544) | 3.88851723 |
| 73 | C4-dicarboxylate transport (GO:0015740) | 3.88685866 |
| 74 | imidazole-containing compound metabolic process (GO:0052803) | 3.87287570 |
| 75 | glutamate metabolic process (GO:0006536) | 3.85995801 |
| 76 | short-chain fatty acid metabolic process (GO:0046459) | 3.83076676 |
| 77 | cholesterol homeostasis (GO:0042632) | 3.81615290 |
| 78 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.80325820 |
| 79 | fatty acid beta-oxidation (GO:0006635) | 3.79982876 |
| 80 | arginine metabolic process (GO:0006525) | 3.78527332 |
| 81 | serine family amino acid metabolic process (GO:0009069) | 3.78249602 |
| 82 | low-density lipoprotein particle remodeling (GO:0034374) | 3.77754784 |
| 83 | regulation of bile acid biosynthetic process (GO:0070857) | 3.77603963 |
| 84 | indolalkylamine metabolic process (GO:0006586) | 3.77474476 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.75772964 |
| 86 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.75772964 |
| 87 | sterol homeostasis (GO:0055092) | 3.75259602 |
| 88 | negative regulation of lipase activity (GO:0060192) | 3.75176957 |
| 89 | fatty acid oxidation (GO:0019395) | 3.72041142 |
| 90 | organic acid catabolic process (GO:0016054) | 3.71142546 |
| 91 | carboxylic acid catabolic process (GO:0046395) | 3.71142546 |
| 92 | benzene-containing compound metabolic process (GO:0042537) | 3.69924704 |
| 93 | nucleobase catabolic process (GO:0046113) | 3.69874087 |
| 94 | cellular modified amino acid catabolic process (GO:0042219) | 3.68575768 |
| 95 | intestinal cholesterol absorption (GO:0030299) | 3.67819249 |
| 96 | monocarboxylic acid catabolic process (GO:0072329) | 3.66589638 |
| 97 | ketone body metabolic process (GO:1902224) | 3.66076146 |
| 98 | flavonoid metabolic process (GO:0009812) | 3.65568639 |
| 99 | lipid oxidation (GO:0034440) | 3.64695582 |
| 100 | fatty acid catabolic process (GO:0009062) | 3.63852058 |
| 101 | cellular biogenic amine catabolic process (GO:0042402) | 3.62148931 |
| 102 | amine catabolic process (GO:0009310) | 3.62148931 |
| 103 | protein-lipid complex assembly (GO:0065005) | 3.61489915 |
| 104 | serine family amino acid biosynthetic process (GO:0009070) | 3.61423900 |
| 105 | neuron recognition (GO:0008038) | 3.60928106 |
| 106 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.60910731 |
| 107 | fibrinolysis (GO:0042730) | 3.58547237 |
| 108 | uronic acid metabolic process (GO:0006063) | 3.56467883 |
| 109 | glucuronate metabolic process (GO:0019585) | 3.56467883 |
| 110 | plasma lipoprotein particle organization (GO:0071827) | 3.54171586 |
| 111 | retinal ganglion cell axon guidance (GO:0031290) | 3.53536805 |
| 112 | 2-oxoglutarate metabolic process (GO:0006103) | 3.53323772 |
| 113 | regulation of cholesterol homeostasis (GO:2000188) | 3.52488315 |
| 114 | auditory behavior (GO:0031223) | 3.50795174 |
| 115 | glial cell proliferation (GO:0014009) | 3.36899186 |
| 116 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.36613236 |
| 117 | exogenous drug catabolic process (GO:0042738) | 3.35000522 |
| 118 | regulation of cilium movement (GO:0003352) | 3.33729777 |
| 119 | neuronal stem cell maintenance (GO:0097150) | 3.33421180 |
| 120 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.21453262 |
| 121 | startle response (GO:0001964) | 3.11886390 |
| 122 | cellular response to leptin stimulus (GO:0044320) | 3.11473614 |
| 123 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.10884878 |
| 124 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.96553642 |
| 125 | fatty acid elongation (GO:0030497) | 2.95092636 |
| 126 | oligodendrocyte differentiation (GO:0048709) | 2.94510852 |
| 127 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.93688622 |
| 128 | vascular smooth muscle contraction (GO:0014829) | 2.93529747 |
| 129 | neurotransmitter uptake (GO:0001504) | 2.89213234 |
| 130 | gamma-aminobutyric acid transport (GO:0015812) | 2.88061667 |
| 131 | neuronal action potential propagation (GO:0019227) | 2.87989217 |
| 132 | omega-hydroxylase P450 pathway (GO:0097267) | 2.79909161 |
| 133 | protein localization to synapse (GO:0035418) | 2.79780429 |
| 134 | synapse assembly (GO:0007416) | 2.77022161 |
| 135 | vocalization behavior (GO:0071625) | 2.75171449 |
| 136 | cellular response to cholesterol (GO:0071397) | 2.74393766 |
| 137 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.74334743 |
| 138 | forebrain neuron differentiation (GO:0021879) | 2.73703303 |
| 139 | oxidative demethylation (GO:0070989) | 2.71108166 |
| 140 | response to auditory stimulus (GO:0010996) | 2.69614432 |
| 141 | positive regulation of synapse assembly (GO:0051965) | 2.68332727 |
| 142 | inner ear receptor stereocilium organization (GO:0060122) | 2.66233718 |
| 143 | epoxygenase P450 pathway (GO:0019373) | 2.65328756 |
| 144 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.64727623 |
| 145 | appendage development (GO:0048736) | 2.64011493 |
| 146 | limb development (GO:0060173) | 2.64011493 |
| 147 | astrocyte differentiation (GO:0048708) | 2.61984337 |
| 148 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.60274287 |
| 149 | retinal cone cell development (GO:0046549) | 2.59271736 |
| 150 | L-serine metabolic process (GO:0006563) | 2.59180674 |
| 151 | response to leptin (GO:0044321) | 2.58929264 |
| 152 | aspartate family amino acid catabolic process (GO:0009068) | 2.58439045 |
| 153 | L-methionine salvage (GO:0071267) | 2.55629559 |
| 154 | L-methionine biosynthetic process (GO:0071265) | 2.55629559 |
| 155 | amino acid salvage (GO:0043102) | 2.55629559 |
| 156 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.55406403 |
| 157 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.53094481 |
| 158 | spinal cord development (GO:0021510) | 2.52867467 |
| 159 | dermatan sulfate biosynthetic process (GO:0030208) | 2.52377708 |
| 160 | sympathetic nervous system development (GO:0048485) | 2.51944725 |
| 161 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.51658641 |
| 162 | response to pheromone (GO:0019236) | 2.50583292 |
| 163 | central nervous system neuron axonogenesis (GO:0021955) | 2.49573115 |
| 164 | regulation of neurotransmitter uptake (GO:0051580) | 2.49183404 |
| 165 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.48028452 |
| 166 | cellular response to sterol (GO:0036315) | 2.47651180 |
| 167 | artery smooth muscle contraction (GO:0014824) | 2.46573414 |
| 168 | retinal rod cell development (GO:0046548) | 2.46150882 |
| 169 | regulation of respiratory system process (GO:0044065) | 2.44612367 |
| 170 | negative regulation of neurotransmitter transport (GO:0051589) | 2.41570077 |
| 171 | acidic amino acid transport (GO:0015800) | 2.38938190 |
| 172 | membrane assembly (GO:0071709) | 2.38736501 |
| 173 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.38275640 |
| 174 | positive regulation of mitochondrial fission (GO:0090141) | 2.36315393 |
| 175 | enteric nervous system development (GO:0048484) | 2.36301016 |
| 176 | cGMP-mediated signaling (GO:0019934) | 2.35927918 |
| 177 | cranial nerve development (GO:0021545) | 2.35607583 |
| 178 | synaptic transmission, glutamatergic (GO:0035249) | 2.35553486 |
| 179 | cilium morphogenesis (GO:0060271) | 2.35542758 |
| 180 | regulation of synapse assembly (GO:0051963) | 2.33354080 |
| 181 | regulation of microtubule-based movement (GO:0060632) | 2.33222766 |
| 182 | glial cell differentiation (GO:0010001) | 2.32778576 |
| 183 | signal peptide processing (GO:0006465) | 2.31569754 |
| 184 | carnitine metabolic process (GO:0009437) | 2.30311335 |
| 185 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.29687132 |
| 186 | response to nitrosative stress (GO:0051409) | 2.29510897 |
| 187 | negative regulation of appetite (GO:0032099) | 2.28681355 |
| 188 | negative regulation of response to food (GO:0032096) | 2.28681355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.80403530 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.67726675 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.30481521 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.27689137 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.23736271 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.90496500 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.53987143 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.98488586 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.77748253 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.55366627 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.47197898 |
| 12 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.80219338 |
| 13 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.58433994 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.56147083 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.52525560 |
| 16 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.52489220 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.45165026 |
| 18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.43306248 |
| 19 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.31428465 |
| 20 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.24897428 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.22511441 |
| 22 | FUS_26573619_Chip-Seq_HEK293_Human | 2.21802206 |
| 23 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.21197287 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.20214329 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.19636635 |
| 26 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.15929976 |
| 27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.12444524 |
| 28 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.10086887 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 2.06219656 |
| 30 | * TAF15_26573619_Chip-Seq_HEK293_Human | 2.03014043 |
| 31 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.01564433 |
| 32 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.9402232 |
| 33 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.99884062 |
| 34 | P300_19829295_ChIP-Seq_ESCs_Human | 1.96902839 |
| 35 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.95890722 |
| 36 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.95139675 |
| 37 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94951168 |
| 38 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.94671906 |
| 39 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.92989806 |
| 40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.76513273 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.73331582 |
| 42 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.72689843 |
| 43 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.71382922 |
| 44 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.70671700 |
| 45 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.67458099 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63065907 |
| 47 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.62171821 |
| 48 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.54974131 |
| 49 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.54974131 |
| 50 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.48007590 |
| 51 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.47558120 |
| 52 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.46258366 |
| 53 | AR_25329375_ChIP-Seq_VCAP_Human | 1.45818612 |
| 54 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.43656280 |
| 55 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.42169719 |
| 56 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.41126457 |
| 57 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.40757973 |
| 58 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.40436227 |
| 59 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40165435 |
| 60 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.39728308 |
| 61 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38594897 |
| 62 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38113504 |
| 63 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.37005363 |
| 64 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.35081972 |
| 65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35006981 |
| 66 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.34696622 |
| 67 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.33489583 |
| 68 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32431003 |
| 69 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.29937458 |
| 70 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.27981252 |
| 71 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.26406512 |
| 72 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.24132596 |
| 73 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.23792414 |
| 74 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.23747945 |
| 75 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.23629585 |
| 76 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.23521560 |
| 77 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.22034264 |
| 78 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.21939872 |
| 79 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.21771117 |
| 80 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.20576996 |
| 81 | TCF4_23295773_ChIP-Seq_U87_Human | 1.19366224 |
| 82 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.18569569 |
| 83 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.18569569 |
| 84 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.17787005 |
| 85 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.15067157 |
| 86 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.14539763 |
| 87 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.14007559 |
| 88 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.13992085 |
| 89 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.13666994 |
| 90 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13660148 |
| 91 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.12926311 |
| 92 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.12654266 |
| 93 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.12135103 |
| 94 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.12074733 |
| 95 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.11688952 |
| 96 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.10660672 |
| 97 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09884855 |
| 98 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.09826509 |
| 99 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.09116884 |
| 100 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08962186 |
| 101 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07906785 |
| 102 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07629823 |
| 103 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.07267411 |
| 104 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.06771312 |
| 105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06503383 |
| 106 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04667535 |
| 107 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.04647566 |
| 108 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.04453665 |
| 109 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.04220485 |
| 110 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04023880 |
| 111 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03980383 |
| 112 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03606732 |
| 113 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.03087637 |
| 114 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.02700966 |
| 115 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02080742 |
| 116 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.01864903 |
| 117 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01377156 |
| 118 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.01073220 |
| 119 | JUN_21703547_ChIP-Seq_K562_Human | 0.99859610 |
| 120 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.98399164 |
| 121 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.96262108 |
| 122 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92726354 |
| 123 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.91475316 |
| 124 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.90521249 |
| 125 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88148187 |
| 126 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88148187 |
| 127 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87974404 |
| 128 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87743010 |
| 129 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.87584588 |
| 130 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.87556461 |
| 131 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.84545097 |
| 132 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.83272019 |
| 133 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82771917 |
| 134 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.82721906 |
| 135 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.80528520 |
| 136 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79471382 |
| 137 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.79108529 |
| 138 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.76978240 |
| 139 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.75973627 |
| 140 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74977211 |
| 141 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.73482624 |
| 142 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.72710130 |
| 143 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70813362 |
| 144 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.67100545 |
| 145 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.66229601 |
| 146 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.65272651 |
| 147 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.64184961 |
| 148 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.63216332 |
| 149 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63118649 |
| 150 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.63018927 |
| 151 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61873091 |
| 152 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.60399258 |
| 153 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.59597716 |
| 154 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.58883946 |
| 155 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.58065934 |
| 156 | CBP_21632823_ChIP-Seq_H3396_Human | 0.57645008 |
| 157 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.57492575 |
| 158 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.57177392 |
| 159 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.57116542 |
| 160 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.56592010 |
| 161 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.56127150 |
| 162 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55835232 |
| 163 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.53706304 |
| 164 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.53448029 |
| 165 | GATA1_19941826_ChIP-Seq_K562_Human | 0.53141113 |
| 166 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.52659358 |
| 167 | GATA2_19941826_ChIP-Seq_K562_Human | 0.52347573 |
| 168 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52101192 |
| 169 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.51984101 |
| 170 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.51855324 |
| 171 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.50198748 |
| 172 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.50127930 |
| 173 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.49477869 |
| 174 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.49477869 |
| 175 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.49152802 |
| 176 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48870777 |
| 177 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.47556880 |
| 178 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.47556536 |
| 179 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.47377502 |
| 180 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.47143756 |
| 181 | AR_20517297_ChIP-Seq_VCAP_Human | 0.46840157 |
| 182 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.46679230 |
| 183 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.46500102 |
| 184 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.46340561 |
| 185 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46259650 |
| 186 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.43556417 |
| 187 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.43331065 |
| 188 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.43316432 |
| 189 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43117910 |
| 190 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.40756378 |
| 191 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.40313810 |
| 192 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.39773554 |
| 193 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39364718 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.88779277 |
| 2 | MP0005360_urolithiasis | 7.42963860 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.10372615 |
| 4 | MP0005365_abnormal_bile_salt | 5.98387099 |
| 5 | MP0003136_yellow_coat_color | 5.72165241 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.89940780 |
| 7 | MP0005171_absent_coat_pigmentation | 4.04889374 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.96787850 |
| 9 | MP0003252_abnormal_bile_duct | 3.84186183 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.77933517 |
| 11 | MP0003880_abnormal_central_pattern | 3.59250228 |
| 12 | MP0002736_abnormal_nociception_after | 3.19180240 |
| 13 | MP0009840_abnormal_foam_cell | 3.06564576 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.83244624 |
| 15 | MP0005083_abnormal_biliary_tract | 2.79695847 |
| 16 | MP0002638_abnormal_pupillary_reflex | 2.76428086 |
| 17 | MP0005332_abnormal_amino_acid | 2.66680763 |
| 18 | MP0003195_calcinosis | 2.44210194 |
| 19 | MP0001984_abnormal_olfaction | 2.43612853 |
| 20 | MP0000778_abnormal_nervous_system | 2.34821313 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.30255085 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 2.27442522 |
| 23 | MP0000609_abnormal_liver_physiology | 2.17351138 |
| 24 | MP0001529_abnormal_vocalization | 2.15182114 |
| 25 | MP0005423_abnormal_somatic_nervous | 2.14299225 |
| 26 | MP0001968_abnormal_touch/_nociception | 2.04132937 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 2.01227138 |
| 28 | MP0001486_abnormal_startle_reflex | 1.93939393 |
| 29 | MP0005253_abnormal_eye_physiology | 1.91802607 |
| 30 | MP0005670_abnormal_white_adipose | 1.83015104 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.77390162 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.76696925 |
| 33 | MP0003868_abnormal_feces_composition | 1.75536166 |
| 34 | MP0004859_abnormal_synaptic_plasticity | 1.73310471 |
| 35 | MP0002938_white_spotting | 1.67533195 |
| 36 | MP0000372_irregular_coat_pigmentation | 1.65944951 |
| 37 | MP0001764_abnormal_homeostasis | 1.64200236 |
| 38 | MP0005551_abnormal_eye_electrophysiolog | 1.63622065 |
| 39 | MP0002734_abnormal_mechanical_nocicepti | 1.58578994 |
| 40 | MP0002272_abnormal_nervous_system | 1.57804446 |
| 41 | MP0009697_abnormal_copulation | 1.56358861 |
| 42 | MP0002751_abnormal_autonomic_nervous | 1.56011404 |
| 43 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55094210 |
| 44 | MP0004270_analgesia | 1.53346051 |
| 45 | MP0005187_abnormal_penis_morphology | 1.53241767 |
| 46 | MP0002102_abnormal_ear_morphology | 1.47311559 |
| 47 | MP0002095_abnormal_skin_pigmentation | 1.46133795 |
| 48 | MP0000955_abnormal_spinal_cord | 1.45698477 |
| 49 | MP0006276_abnormal_autonomic_nervous | 1.45272857 |
| 50 | MP0005451_abnormal_body_composition | 1.43950478 |
| 51 | MP0002653_abnormal_ependyma_morphology | 1.43064980 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 1.39178169 |
| 53 | MP0003635_abnormal_synaptic_transmissio | 1.38858833 |
| 54 | MP0004130_abnormal_muscle_cell | 1.37820480 |
| 55 | MP0002254_reproductive_system_inflammat | 1.35674884 |
| 56 | MP0002557_abnormal_social/conspecific_i | 1.33801072 |
| 57 | MP0004885_abnormal_endolymph | 1.31795592 |
| 58 | MP0006072_abnormal_retinal_apoptosis | 1.31369225 |
| 59 | MP0002876_abnormal_thyroid_physiology | 1.29068132 |
| 60 | MP0000647_abnormal_sebaceous_gland | 1.28919398 |
| 61 | MP0003186_abnormal_redox_activity | 1.28905987 |
| 62 | MP0002909_abnormal_adrenal_gland | 1.27648355 |
| 63 | MP0001986_abnormal_taste_sensitivity | 1.27049512 |
| 64 | MP0002572_abnormal_emotion/affect_behav | 1.27021136 |
| 65 | MP0002063_abnormal_learning/memory/cond | 1.25444660 |
| 66 | MP0009745_abnormal_behavioral_response | 1.25263511 |
| 67 | MP0000026_abnormal_inner_ear | 1.24326640 |
| 68 | MP0009643_abnormal_urine_homeostasis | 1.24008612 |
| 69 | MP0001485_abnormal_pinna_reflex | 1.23132781 |
| 70 | MP0002233_abnormal_nose_morphology | 1.21263008 |
| 71 | MP0005666_abnormal_adipose_tissue | 1.19520653 |
| 72 | MP0000569_abnormal_digit_pigmentation | 1.19281501 |
| 73 | MP0003011_delayed_dark_adaptation | 1.19214727 |
| 74 | MP0002234_abnormal_pharynx_morphology | 1.18887543 |
| 75 | MP0001502_abnormal_circadian_rhythm | 1.16666380 |
| 76 | MP0005391_vision/eye_phenotype | 1.15864883 |
| 77 | MP0002735_abnormal_chemical_nociception | 1.15453351 |
| 78 | MP0002971_abnormal_brown_adipose | 1.15445721 |
| 79 | MP0003755_abnormal_palate_morphology | 1.14298231 |
| 80 | MP0001970_abnormal_pain_threshold | 1.14204099 |
| 81 | MP0002064_seizures | 1.14156578 |
| 82 | MP0000598_abnormal_liver_morphology | 1.11154316 |
| 83 | MP0001324_abnormal_eye_pigmentation | 1.10358254 |
| 84 | MP0008789_abnormal_olfactory_epithelium | 1.10239535 |
| 85 | MP0002184_abnormal_innervation | 1.09968867 |
| 86 | MP0002882_abnormal_neuron_morphology | 1.09560512 |
| 87 | MP0005174_abnormal_tail_pigmentation | 1.08988723 |
| 88 | MP0005647_abnormal_sex_gland | 1.08301291 |
| 89 | MP0001177_atelectasis | 1.07699878 |
| 90 | MP0002837_dystrophic_cardiac_calcinosis | 1.06616877 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 1.05982930 |
| 92 | MP0002752_abnormal_somatic_nervous | 1.05262198 |
| 93 | MP0002282_abnormal_trachea_morphology | 1.04969936 |
| 94 | MP0002090_abnormal_vision | 1.04759419 |
| 95 | MP0005195_abnormal_posterior_eye | 1.02675211 |
| 96 | MP0002067_abnormal_sensory_capabilities | 1.02097023 |
| 97 | MP0001293_anophthalmia | 1.01287037 |
| 98 | MP0005334_abnormal_fat_pad | 1.01207440 |
| 99 | MP0003122_maternal_imprinting | 1.00735275 |
| 100 | MP0000604_amyloidosis | 1.00735119 |
| 101 | MP0002152_abnormal_brain_morphology | 1.00234240 |
| 102 | MP0001661_extended_life_span | 1.00164571 |
| 103 | MP0005646_abnormal_pituitary_gland | 1.00109568 |
| 104 | MP0004142_abnormal_muscle_tone | 0.99404236 |
| 105 | MP0000049_abnormal_middle_ear | 0.98057316 |
| 106 | MP0003385_abnormal_body_wall | 0.97109715 |
| 107 | MP0005386_behavior/neurological_phenoty | 0.96507371 |
| 108 | MP0004924_abnormal_behavior | 0.96507371 |
| 109 | MP0000631_abnormal_neuroendocrine_gland | 0.96345830 |
| 110 | MP0000534_abnormal_ureter_morphology | 0.94121621 |
| 111 | MP0003690_abnormal_glial_cell | 0.92469230 |
| 112 | * MP0009763_increased_sensitivity_to | 0.92451917 |
| 113 | MP0009764_decreased_sensitivity_to | 0.92148336 |
| 114 | MP0003861_abnormal_nervous_system | 0.91497744 |
| 115 | MP0003632_abnormal_nervous_system | 0.91021389 |
| 116 | MP0003634_abnormal_glial_cell | 0.90729485 |
| 117 | MP0005394_taste/olfaction_phenotype | 0.89828542 |
| 118 | MP0005499_abnormal_olfactory_system | 0.89828542 |
| 119 | MP0002078_abnormal_glucose_homeostasis | 0.89301301 |
| 120 | MP0002697_abnormal_eye_size | 0.88946666 |
| 121 | MP0002733_abnormal_thermal_nociception | 0.88786245 |
| 122 | MP0001963_abnormal_hearing_physiology | 0.88028279 |
| 123 | MP0006036_abnormal_mitochondrial_physio | 0.86721011 |
| 124 | MP0003937_abnormal_limbs/digits/tail_de | 0.85194643 |
| 125 | MP0004133_heterotaxia | 0.84413591 |
| 126 | MP0003121_genomic_imprinting | 0.84003437 |
| 127 | MP0005084_abnormal_gallbladder_morpholo | 0.83150305 |
| 128 | MP0005535_abnormal_body_temperature | 0.83100546 |
| 129 | MP0010368_abnormal_lymphatic_system | 0.81827241 |
| 130 | MP0009642_abnormal_blood_homeostasis | 0.81424406 |
| 131 | MP0001286_abnormal_eye_development | 0.81424386 |
| 132 | MP0005448_abnormal_energy_balance | 0.81123820 |
| 133 | MP0004811_abnormal_neuron_physiology | 0.80960178 |
| 134 | MP0001905_abnormal_dopamine_level | 0.79937266 |
| 135 | MP0005376_homeostasis/metabolism_phenot | 0.78564035 |
| 136 | MP0009046_muscle_twitch | 0.77509639 |
| 137 | MP0005636_abnormal_mineral_homeostasis | 0.77502536 |
| 138 | MP0005408_hypopigmentation | 0.77497677 |
| 139 | MP0004185_abnormal_adipocyte_glucose | 0.76531956 |
| 140 | MP0003119_abnormal_digestive_system | 0.74359280 |
| 141 | MP0008469_abnormal_protein_level | 0.73930934 |
| 142 | MP0003935_abnormal_craniofacial_develop | 0.73495996 |
| 143 | MP0009115_abnormal_fat_cell | 0.72364370 |
| 144 | MP0003942_abnormal_urinary_system | 0.70376046 |
| 145 | MP0004742_abnormal_vestibular_system | 0.70353432 |
| 146 | MP0000516_abnormal_urinary_system | 0.69725442 |
| 147 | MP0005375_adipose_tissue_phenotype | 0.69049224 |
| 148 | MP0005266_abnormal_metabolism | 0.68141251 |
| 149 | MP0001756_abnormal_urination | 0.64863489 |
| 150 | * MP0009765_abnormal_xenobiotic_induced | 0.62428170 |
| 151 | MP0005220_abnormal_exocrine_pancreas | 0.61922472 |
| 152 | MP0003329_amyloid_beta_deposits | 0.60055228 |
| 153 | MP0009053_abnormal_anal_canal | 0.59900740 |
| 154 | MP0002970_abnormal_white_adipose | 0.55829105 |
| 155 | MP0000639_abnormal_adrenal_gland | 0.51538450 |
| 156 | MP0010234_abnormal_vibrissa_follicle | 0.48409473 |
| 157 | MP0003953_abnormal_hormone_level | 0.47383347 |
| 158 | MP0003959_abnormal_lean_body | 0.47371106 |
| 159 | MP0009384_cardiac_valve_regurgitation | 0.47069314 |
| 160 | MP0002796_impaired_skin_barrier | 0.46132885 |
| 161 | MP0006035_abnormal_mitochondrial_morpho | 0.45708582 |
| 162 | MP0008438_abnormal_cutaneous_collagen | 0.45353790 |
| 163 | MP0001881_abnormal_mammary_gland | 0.44260203 |
| 164 | MP0005395_other_phenotype | 0.43704372 |
| 165 | MP0003638_abnormal_response/metabolism_ | 0.43226557 |
| 166 | MP0002136_abnormal_kidney_physiology | 0.43180374 |
| 167 | MP0005248_abnormal_Harderian_gland | 0.42480094 |
| 168 | MP0008872_abnormal_physiological_respon | 0.42374655 |
| 169 | MP0004147_increased_porphyrin_level | 0.41890123 |
| 170 | MP0000230_abnormal_systemic_arterial | 0.41650298 |
| 171 | MP0002928_abnormal_bile_duct | 0.40428969 |
| 172 | MP0002822_catalepsy | 0.40382825 |
| 173 | MP0009672_abnormal_birth_weight | 0.40153654 |
| 174 | MP0003724_increased_susceptibility_to | 0.39665307 |
| 175 | MP0008874_decreased_physiological_sensi | 0.38130723 |
| 176 | MP0002168_other_aberrant_phenotype | 0.37094061 |
| 177 | MP0002060_abnormal_skin_morphology | 0.36187198 |
| 178 | MP0005167_abnormal_blood-brain_barrier | 0.35605753 |
| 179 | MP0000249_abnormal_blood_vessel | 0.35369375 |
| 180 | MP0000427_abnormal_hair_cycle | 0.35114446 |
| 181 | MP0004782_abnormal_surfactant_physiolog | 0.34486357 |
| 182 | MP0004264_abnormal_extraembryonic_tissu | 0.33460487 |
| 183 | MP0005330_cardiomyopathy | 0.32278535 |
| 184 | MP0003075_altered_response_to | 0.31838330 |
| 185 | MP0005164_abnormal_response_to | 0.31658838 |
| 186 | MP0005452_abnormal_adipose_tissue | 0.30746528 |
| 187 | MP0004883_abnormal_blood_vessel | 0.30679852 |
| 188 | MP0005464_abnormal_platelet_physiology | 0.30095884 |
| 189 | MP0000003_abnormal_adipose_tissue | 0.29861679 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.01218805 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.92238281 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.83631244 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.37034171 |
| 5 | Xanthomatosis (HP:0000991) | 6.21374693 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.20389648 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.90466304 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.42890076 |
| 9 | Complement deficiency (HP:0004431) | 5.03732300 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.87729995 |
| 11 | Hyperammonemia (HP:0001987) | 4.74000180 |
| 12 | Epidermoid cyst (HP:0200040) | 4.73322774 |
| 13 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.55494114 |
| 14 | Hyperglycinuria (HP:0003108) | 4.36508329 |
| 15 | Hyperglycinemia (HP:0002154) | 4.34551983 |
| 16 | Ketosis (HP:0001946) | 4.32008903 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.30945976 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.26192354 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 4.25303963 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.25303963 |
| 21 | Joint hemorrhage (HP:0005261) | 4.20353262 |
| 22 | Hypoglycemic coma (HP:0001325) | 4.20043592 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 4.13664713 |
| 24 | Fat malabsorption (HP:0002630) | 4.06179148 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.02482116 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.99842166 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.98842805 |
| 28 | Hypercholesterolemia (HP:0003124) | 3.81516857 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.75226834 |
| 30 | Abnormality of complement system (HP:0005339) | 3.59746113 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.58861437 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.56514368 |
| 33 | Gait imbalance (HP:0002141) | 3.52192243 |
| 34 | Split foot (HP:0001839) | 3.48078652 |
| 35 | Medial flaring of the eyebrow (HP:0010747) | 3.47973063 |
| 36 | Abnormality of the intrinsic pathway (HP:0010989) | 3.44350922 |
| 37 | Hemiparesis (HP:0001269) | 3.40528370 |
| 38 | Congenital primary aphakia (HP:0007707) | 3.31293393 |
| 39 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.29910939 |
| 40 | True hermaphroditism (HP:0010459) | 3.27423324 |
| 41 | Ketoacidosis (HP:0001993) | 3.25025478 |
| 42 | Nephrogenic diabetes insipidus (HP:0009806) | 3.23837112 |
| 43 | Hyperbilirubinemia (HP:0002904) | 3.20537361 |
| 44 | Focal motor seizures (HP:0011153) | 3.06220497 |
| 45 | Abnormality of serum amino acid levels (HP:0003112) | 3.01146030 |
| 46 | Patchy hypopigmentation of hair (HP:0011365) | 2.99781897 |
| 47 | Skin nodule (HP:0200036) | 2.97568460 |
| 48 | White forelock (HP:0002211) | 2.97292984 |
| 49 | Hyperventilation (HP:0002883) | 2.96657736 |
| 50 | Abnormality of the labia minora (HP:0012880) | 2.93265419 |
| 51 | Delayed CNS myelination (HP:0002188) | 2.91787143 |
| 52 | Acanthocytosis (HP:0001927) | 2.91323722 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.91020775 |
| 54 | Hepatocellular carcinoma (HP:0001402) | 2.89664132 |
| 55 | Steatorrhea (HP:0002570) | 2.87247523 |
| 56 | Myocardial infarction (HP:0001658) | 2.84124010 |
| 57 | Metabolic acidosis (HP:0001942) | 2.82570504 |
| 58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.80642227 |
| 59 | Dicarboxylic aciduria (HP:0003215) | 2.80642227 |
| 60 | Genital tract atresia (HP:0001827) | 2.76628328 |
| 61 | Vaginal atresia (HP:0000148) | 2.75249162 |
| 62 | Abnormality of purine metabolism (HP:0004352) | 2.71575694 |
| 63 | Lethargy (HP:0001254) | 2.65511042 |
| 64 | Hypoglycemic seizures (HP:0002173) | 2.60946514 |
| 65 | Spontaneous abortion (HP:0005268) | 2.59806923 |
| 66 | Hypochromic microcytic anemia (HP:0004840) | 2.59303546 |
| 67 | Broad foot (HP:0001769) | 2.54867370 |
| 68 | Renal hypoplasia (HP:0000089) | 2.54264208 |
| 69 | Cerebral edema (HP:0002181) | 2.52560109 |
| 70 | Intestinal atresia (HP:0011100) | 2.51778247 |
| 71 | Blue irides (HP:0000635) | 2.51066826 |
| 72 | Action tremor (HP:0002345) | 2.49448360 |
| 73 | Abnormality of the ischium (HP:0003174) | 2.48371476 |
| 74 | Abnormal gallbladder morphology (HP:0012437) | 2.47338471 |
| 75 | Congenital sensorineural hearing impairment (HP:0008527) | 2.45355203 |
| 76 | Systemic lupus erythematosus (HP:0002725) | 2.44200218 |
| 77 | Pancreatic fibrosis (HP:0100732) | 2.44089162 |
| 78 | Chronic hepatic failure (HP:0100626) | 2.43649252 |
| 79 | Oligodactyly (hands) (HP:0001180) | 2.43236729 |
| 80 | Cholelithiasis (HP:0001081) | 2.41022033 |
| 81 | Malnutrition (HP:0004395) | 2.39596938 |
| 82 | Spastic diplegia (HP:0001264) | 2.38621861 |
| 83 | Poor coordination (HP:0002370) | 2.35298939 |
| 84 | Vascular calcification (HP:0004934) | 2.34566629 |
| 85 | Occipital encephalocele (HP:0002085) | 2.32531425 |
| 86 | Hemiplegia (HP:0002301) | 2.31002061 |
| 87 | Postaxial hand polydactyly (HP:0001162) | 2.30657813 |
| 88 | Pancreatitis (HP:0001733) | 2.29008651 |
| 89 | Esophageal varix (HP:0002040) | 2.26481583 |
| 90 | Hydroxyprolinuria (HP:0003080) | 2.25843568 |
| 91 | Abnormality of proline metabolism (HP:0010907) | 2.25843568 |
| 92 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.25227839 |
| 93 | Glomerulonephritis (HP:0000099) | 2.24782040 |
| 94 | Cholecystitis (HP:0001082) | 2.24781208 |
| 95 | Abnormal gallbladder physiology (HP:0012438) | 2.24781208 |
| 96 | Abnormality of midbrain morphology (HP:0002418) | 2.24699114 |
| 97 | Molar tooth sign on MRI (HP:0002419) | 2.24699114 |
| 98 | Amyloidosis (HP:0011034) | 2.22432665 |
| 99 | Retinal dysplasia (HP:0007973) | 2.22076448 |
| 100 | Hemorrhage of the eye (HP:0011885) | 2.21939111 |
| 101 | Hypertriglyceridemia (HP:0002155) | 2.20410568 |
| 102 | Irritability (HP:0000737) | 2.20404789 |
| 103 | Megalencephaly (HP:0001355) | 2.19569045 |
| 104 | Gastrointestinal atresia (HP:0002589) | 2.18208492 |
| 105 | Pancreatic cysts (HP:0001737) | 2.18013379 |
| 106 | Polyphagia (HP:0002591) | 2.17871009 |
| 107 | Brushfield spots (HP:0001088) | 2.15737179 |
| 108 | Pheochromocytoma (HP:0002666) | 2.15343128 |
| 109 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.14690711 |
| 110 | Gout (HP:0001997) | 2.14609736 |
| 111 | Cardiovascular calcification (HP:0011915) | 2.13821065 |
| 112 | Mitral stenosis (HP:0001718) | 2.13031425 |
| 113 | Vomiting (HP:0002013) | 2.10842113 |
| 114 | Heterochromia iridis (HP:0001100) | 2.10563797 |
| 115 | Generalized aminoaciduria (HP:0002909) | 2.09387313 |
| 116 | Large for gestational age (HP:0001520) | 2.08373660 |
| 117 | Poikilocytosis (HP:0004447) | 2.08065772 |
| 118 | Septo-optic dysplasia (HP:0100842) | 2.05472103 |
| 119 | Cortical dysplasia (HP:0002539) | 2.05021850 |
| 120 | Enlarged kidneys (HP:0000105) | 2.04802827 |
| 121 | Nephronophthisis (HP:0000090) | 2.03790789 |
| 122 | Abnormal cartilage morphology (HP:0002763) | 2.02737801 |
| 123 | Late onset (HP:0003584) | 2.02643839 |
| 124 | Generalized tonic-clonic seizures (HP:0002069) | 2.02345479 |
| 125 | Exercise-induced muscle cramps (HP:0003710) | 2.02297744 |
| 126 | Cutaneous finger syndactyly (HP:0010554) | 2.01376328 |
| 127 | Optic nerve hypoplasia (HP:0000609) | 2.00985957 |
| 128 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.00450108 |
| 129 | Hypoplasia of the fovea (HP:0007750) | 2.00450108 |
| 130 | Neonatal onset (HP:0003623) | 2.00418504 |
| 131 | Esophageal atresia (HP:0002032) | 2.00171025 |
| 132 | Hyperglycemia (HP:0003074) | 1.99399336 |
| 133 | Methylmalonic acidemia (HP:0002912) | 1.99022493 |
| 134 | Specific learning disability (HP:0001328) | 1.97761721 |
| 135 | Abnormality of the diencephalon (HP:0010662) | 1.97593765 |
| 136 | Hemivertebrae (HP:0002937) | 1.95119897 |
| 137 | Absent speech (HP:0001344) | 1.95111694 |
| 138 | Sensorimotor neuropathy (HP:0007141) | 1.94547495 |
| 139 | Alacrima (HP:0000522) | 1.93608560 |
| 140 | Abnormality of the gallbladder (HP:0005264) | 1.93330474 |
| 141 | Renal cortical cysts (HP:0000803) | 1.91946546 |
| 142 | Long clavicles (HP:0000890) | 1.91651232 |
| 143 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.91641055 |
| 144 | Abnormal biliary tract physiology (HP:0012439) | 1.90425301 |
| 145 | Bile duct proliferation (HP:0001408) | 1.90425301 |
| 146 | Lissencephaly (HP:0001339) | 1.89885981 |
| 147 | Oligodactyly (HP:0012165) | 1.88915904 |
| 148 | Gingival bleeding (HP:0000225) | 1.88857608 |
| 149 | Albinism (HP:0001022) | 1.86900280 |
| 150 | Opisthotonus (HP:0002179) | 1.86364328 |
| 151 | Ileus (HP:0002595) | 1.85883492 |
| 152 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.85614683 |
| 153 | Abnormality of vitamin metabolism (HP:0100508) | 1.85391240 |
| 154 | Type II lissencephaly (HP:0007260) | 1.84523444 |
| 155 | Hypoplastic ischia (HP:0003175) | 1.84398266 |
| 156 | Postaxial foot polydactyly (HP:0001830) | 1.83902653 |
| 157 | Focal seizures (HP:0007359) | 1.83713194 |
| 158 | Abnormality of the 4th metacarpal (HP:0010012) | 1.83537667 |
| 159 | Pigmentary retinal degeneration (HP:0001146) | 1.83192840 |
| 160 | Hypopigmentation of the fundus (HP:0007894) | 1.82919666 |
| 161 | Elevated hepatic transaminases (HP:0002910) | 1.82435146 |
| 162 | Nausea (HP:0002018) | 1.81873056 |
| 163 | Glycosuria (HP:0003076) | 1.81763546 |
| 164 | Abnormality of urine glucose concentration (HP:0011016) | 1.81763546 |
| 165 | Drooling (HP:0002307) | 1.81725968 |
| 166 | Menorrhagia (HP:0000132) | 1.80307666 |
| 167 | Neuroendocrine neoplasm (HP:0100634) | 1.80019614 |
| 168 | Short 4th metacarpal (HP:0010044) | 1.79540474 |
| 169 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.79540474 |
| 170 | Proximal tubulopathy (HP:0000114) | 1.78784482 |
| 171 | Thrombophlebitis (HP:0004418) | 1.78557097 |
| 172 | Abnormality of iron homeostasis (HP:0011031) | 1.78074880 |
| 173 | Hepatoblastoma (HP:0002884) | 1.78015679 |
| 174 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.77822196 |
| 175 | Tubulointerstitial nephritis (HP:0001970) | 1.77277409 |
| 176 | Astigmatism (HP:0000483) | 1.76403458 |
| 177 | Short foot (HP:0001773) | 1.74909375 |
| 178 | Bifid scrotum (HP:0000048) | 1.74299115 |
| 179 | Gonadotropin excess (HP:0000837) | 1.73196762 |
| 180 | Cystic liver disease (HP:0006706) | 1.73103787 |
| 181 | Anencephaly (HP:0002323) | 1.71944837 |
| 182 | Decreased testicular size (HP:0008734) | 1.71716960 |
| 183 | Decreased lacrimation (HP:0000633) | 1.71374385 |
| 184 | Narrow forehead (HP:0000341) | 1.70540110 |
| 185 | Vitreoretinal degeneration (HP:0000655) | 1.70415080 |
| 186 | Tented upper lip vermilion (HP:0010804) | 1.70006985 |
| 187 | Short tibia (HP:0005736) | 1.68758418 |
| 188 | Abnormality of the fovea (HP:0000493) | 1.68721637 |
| 189 | Chorioretinal atrophy (HP:0000533) | 1.67722025 |
| 190 | Coronal craniosynostosis (HP:0004440) | 1.67222942 |
| 191 | Micropenis (HP:0000054) | 1.66598761 |
| 192 | Abnormal finger flexion creases (HP:0006143) | 1.66539475 |
| 193 | Anophthalmia (HP:0000528) | 1.65908672 |
| 194 | Sclerocornea (HP:0000647) | 1.65515995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.50684747 |
| 2 | SIK1 | 4.66691475 |
| 3 | CASK | 4.10494561 |
| 4 | MARK1 | 3.84752648 |
| 5 | FGFR4 | 3.62208758 |
| 6 | INSRR | 3.21830997 |
| 7 | EPHA4 | 3.20126343 |
| 8 | ERN1 | 3.09292760 |
| 9 | TRIM28 | 2.99980158 |
| 10 | FRK | 2.91329882 |
| 11 | PNCK | 2.90027287 |
| 12 | MST1R | 2.75323012 |
| 13 | CAMK1D | 2.44231868 |
| 14 | TRIB3 | 2.43443407 |
| 15 | BCR | 2.38890845 |
| 16 | TNIK | 2.30498703 |
| 17 | ERBB4 | 2.29837337 |
| 18 | WNK3 | 2.27492745 |
| 19 | MKNK2 | 2.22404317 |
| 20 | PKN2 | 2.18483636 |
| 21 | NTRK2 | 2.08631508 |
| 22 | MAPK13 | 2.08593002 |
| 23 | LATS1 | 2.05052902 |
| 24 | LMTK2 | 2.03738062 |
| 25 | FGFR2 | 2.01836445 |
| 26 | MAP4K2 | 1.97268163 |
| 27 | MKNK1 | 1.91488770 |
| 28 | TAOK3 | 1.88568941 |
| 29 | MAP3K4 | 1.80206828 |
| 30 | WEE1 | 1.71331178 |
| 31 | MAP2K4 | 1.65654118 |
| 32 | CCNB1 | 1.62227531 |
| 33 | PRKAA2 | 1.61560404 |
| 34 | MET | 1.60691802 |
| 35 | TSSK6 | 1.58395552 |
| 36 | NEK1 | 1.57785001 |
| 37 | PTK6 | 1.55981005 |
| 38 | DYRK2 | 1.55784844 |
| 39 | CAMK1G | 1.53764540 |
| 40 | MAPK11 | 1.53042724 |
| 41 | PIK3CG | 1.52778048 |
| 42 | FLT3 | 1.51060261 |
| 43 | ERBB3 | 1.50464100 |
| 44 | MAP2K7 | 1.43897150 |
| 45 | PLK2 | 1.35316350 |
| 46 | CSNK1G3 | 1.29034934 |
| 47 | RIPK1 | 1.28153775 |
| 48 | TYK2 | 1.25064278 |
| 49 | NEK9 | 1.24641954 |
| 50 | EPHB1 | 1.21935431 |
| 51 | DAPK2 | 1.14823081 |
| 52 | MAP3K7 | 1.10640584 |
| 53 | BUB1 | 1.10420723 |
| 54 | PRKCG | 1.08553409 |
| 55 | PDK3 | 1.08436947 |
| 56 | PDK4 | 1.08436947 |
| 57 | PIK3CA | 1.07300273 |
| 58 | ABL2 | 1.07073170 |
| 59 | JAK2 | 1.04700115 |
| 60 | DYRK1A | 1.03158021 |
| 61 | BMPR1B | 1.00878704 |
| 62 | ERBB2 | 0.98983793 |
| 63 | NTRK3 | 0.96951465 |
| 64 | TIE1 | 0.95627705 |
| 65 | KDR | 0.95203398 |
| 66 | PINK1 | 0.94673067 |
| 67 | PRKD3 | 0.94445748 |
| 68 | PAK6 | 0.94129589 |
| 69 | CDK6 | 0.93726991 |
| 70 | BRSK2 | 0.90335713 |
| 71 | PRKAA1 | 0.89348875 |
| 72 | JAK1 | 0.89093788 |
| 73 | FGFR3 | 0.87995474 |
| 74 | ADRBK2 | 0.87153832 |
| 75 | STK16 | 0.85779089 |
| 76 | UHMK1 | 0.84482505 |
| 77 | MINK1 | 0.84391508 |
| 78 | PLK3 | 0.82902395 |
| 79 | PRKACG | 0.81891451 |
| 80 | MAP3K10 | 0.80176557 |
| 81 | PRKCE | 0.79040100 |
| 82 | GSK3A | 0.77460568 |
| 83 | BRSK1 | 0.77170450 |
| 84 | PRKCZ | 0.75729165 |
| 85 | ROCK2 | 0.75370548 |
| 86 | EPHA3 | 0.72890795 |
| 87 | CDK3 | 0.72875652 |
| 88 | MYLK | 0.72291627 |
| 89 | NTRK1 | 0.70531161 |
| 90 | MAPK4 | 0.70324810 |
| 91 | SRPK1 | 0.70303330 |
| 92 | PDK2 | 0.69477880 |
| 93 | PDPK1 | 0.68253666 |
| 94 | STK38L | 0.67532508 |
| 95 | MAPKAPK5 | 0.66337164 |
| 96 | KSR1 | 0.65118980 |
| 97 | DYRK1B | 0.64629411 |
| 98 | CAMK2G | 0.64160602 |
| 99 | GRK6 | 0.64121231 |
| 100 | VRK1 | 0.63561509 |
| 101 | TBK1 | 0.62203026 |
| 102 | MAP3K3 | 0.62118342 |
| 103 | EIF2AK3 | 0.61048984 |
| 104 | CSNK1G1 | 0.60606067 |
| 105 | PTK2 | 0.59443467 |
| 106 | MAP2K1 | 0.59017245 |
| 107 | MAPK12 | 0.58857173 |
| 108 | RET | 0.58671316 |
| 109 | YES1 | 0.58475648 |
| 110 | PRKG2 | 0.58382879 |
| 111 | MAP2K3 | 0.57787022 |
| 112 | ICK | 0.56988763 |
| 113 | NUAK1 | 0.56849033 |
| 114 | CSK | 0.56598706 |
| 115 | IGF1R | 0.56529427 |
| 116 | MAP3K14 | 0.55809202 |
| 117 | CAMK2A | 0.55312893 |
| 118 | CAMK2B | 0.55077301 |
| 119 | PLK4 | 0.52534412 |
| 120 | OBSCN | 0.52023600 |
| 121 | CDK5 | 0.51907024 |
| 122 | ROCK1 | 0.51500277 |
| 123 | TGFBR2 | 0.51168806 |
| 124 | PDGFRA | 0.51084206 |
| 125 | DMPK | 0.50748613 |
| 126 | PHKG2 | 0.50003680 |
| 127 | PHKG1 | 0.50003680 |
| 128 | SGK2 | 0.48495711 |
| 129 | CDK18 | 0.48414062 |
| 130 | EPHB2 | 0.48235706 |
| 131 | PRKCQ | 0.47606479 |
| 132 | GRK1 | 0.46911163 |
| 133 | CSNK1D | 0.46897911 |
| 134 | MTOR | 0.46503986 |
| 135 | SGK3 | 0.45487806 |
| 136 | IRAK3 | 0.45081581 |
| 137 | PAK3 | 0.44249741 |
| 138 | TTK | 0.44097716 |
| 139 | PRKACA | 0.43845968 |
| 140 | PDK1 | 0.41966040 |
| 141 | MAPK15 | 0.41957502 |
| 142 | PRKDC | 0.41349655 |
| 143 | PLK1 | 0.40382816 |
| 144 | PKN1 | 0.40003818 |
| 145 | PRKACB | 0.39921250 |
| 146 | GRK7 | 0.39742649 |
| 147 | CAMK2D | 0.39322235 |
| 148 | PBK | 0.39022265 |
| 149 | CDK15 | 0.38926462 |
| 150 | FGFR1 | 0.38691235 |
| 151 | STK3 | 0.38443022 |
| 152 | RPS6KA5 | 0.38267555 |
| 153 | FER | 0.38024268 |
| 154 | LIMK1 | 0.37659827 |
| 155 | MAPK7 | 0.37593239 |
| 156 | MAP3K2 | 0.37341342 |
| 157 | MAP2K2 | 0.36175057 |
| 158 | CDK11A | 0.35315057 |
| 159 | CSF1R | 0.34942811 |
| 160 | PRKD1 | 0.33980029 |
| 161 | STK39 | 0.33933590 |
| 162 | MAP2K6 | 0.33811470 |
| 163 | CDK4 | 0.33113117 |
| 164 | SGK494 | 0.32579030 |
| 165 | SGK223 | 0.32579030 |
| 166 | BMX | 0.31616322 |
| 167 | CSNK1G2 | 0.28397571 |
| 168 | CSNK1A1L | 0.27385571 |
| 169 | AKT3 | 0.25966114 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.03393187 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.76832173 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.17751347 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.05226012 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.98008461 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68386492 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.62058296 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.58376061 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.57415671 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.57072253 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.44213015 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.37710919 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.32142838 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.15219125 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14682857 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.13222926 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11721096 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.05540667 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.03138630 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88588264 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86312851 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.86084062 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.85607568 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.79389412 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.76280394 |
| 26 | Protein export_Homo sapiens_hsa03060 | 1.70212612 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.69876811 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65395188 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63380220 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.62487347 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60126334 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58165462 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.57643514 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.57339207 |
| 35 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.56763904 |
| 36 | Nicotine addiction_Homo sapiens_hsa05033 | 1.55923507 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.54072099 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.49338957 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.48574191 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.46612136 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41538908 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38605311 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.37224134 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.36549803 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.25563159 |
| 46 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.22632415 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.21462554 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17001906 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15634156 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14944537 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.14142297 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06621959 |
| 53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.99860135 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.98580818 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.97937640 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96907796 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94926472 |
| 58 | GABAergic synapse_Homo sapiens_hsa04727 | 0.94674445 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94118081 |
| 60 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.94050988 |
| 61 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.93347692 |
| 62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.92590694 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91903561 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.91154626 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90031471 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87439982 |
| 67 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.82878678 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81380187 |
| 69 | Lysine degradation_Homo sapiens_hsa00310 | 0.80251032 |
| 70 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.78876401 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.74268840 |
| 72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73375742 |
| 73 | Cocaine addiction_Homo sapiens_hsa05030 | 0.70610357 |
| 74 | Circadian entrainment_Homo sapiens_hsa04713 | 0.68652193 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68375739 |
| 76 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.67814112 |
| 77 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.65310825 |
| 78 | Axon guidance_Homo sapiens_hsa04360 | 0.63596723 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60686436 |
| 80 | Parkinsons disease_Homo sapiens_hsa05012 | 0.60044937 |
| 81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.59645533 |
| 82 | Morphine addiction_Homo sapiens_hsa05032 | 0.59643975 |
| 83 | Phototransduction_Homo sapiens_hsa04744 | 0.59136136 |
| 84 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.56421621 |
| 85 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.55699015 |
| 86 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.55520016 |
| 87 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.54489271 |
| 88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51876609 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51847152 |
| 90 | Taste transduction_Homo sapiens_hsa04742 | 0.51688365 |
| 91 | Basal transcription factors_Homo sapiens_hsa03022 | 0.49761691 |
| 92 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.48828580 |
| 93 | RNA polymerase_Homo sapiens_hsa03020 | 0.48131276 |
| 94 | Insulin secretion_Homo sapiens_hsa04911 | 0.46544394 |
| 95 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.45802453 |
| 96 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45384290 |
| 97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45343708 |
| 98 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.43080494 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42670129 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38876076 |
| 101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35038040 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.33588616 |
| 103 | Huntingtons disease_Homo sapiens_hsa05016 | 0.33386572 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33006377 |
| 105 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.31917745 |
| 106 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29420777 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29378006 |
| 108 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.29169881 |
| 109 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.28474192 |
| 110 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.26582100 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24610077 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.22387106 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.18597543 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15742712 |
| 115 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.07303105 |
| 116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.03196410 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.03114157 |
| 118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.01975908 |
| 119 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.2370050 |
| 120 | Amoebiasis_Homo sapiens_hsa05146 | -0.2064335 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1858870 |
| 122 | Hepatitis C_Homo sapiens_hsa05160 | -0.1766986 |
| 123 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1708954 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1651361 |
| 125 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1633910 |
| 126 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1627056 |
| 127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1522637 |
| 128 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1417406 |
| 129 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1184071 |
| 130 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1054548 |
| 131 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0958584 |
| 132 | Mineral absorption_Homo sapiens_hsa04978 | -0.0888717 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0624761 |
| 134 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0595366 |
| 135 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0338838 |

